Canonical Wnt-β-catenin driven carcinogenesis is characterized by increased accumulation of β-catenin and TCF/LEF complexes in the nucleus leading to inappropriate activation of Wnt target genes; thus making β-catenin an enticing molecular target for CRC therapy [5]. Here, HNF4A is linked to colorectal carcinoma.